Aug 10 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2022 Jun 30, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9 mln 7 mln 289 mln
(+26.7 pct) (-50.4 pct)
Operating loss 374 mln loss 471 mln loss 1.00
Recurring loss 382 mln loss 475 mln loss 1.00
Net loss 381 mln loss 473 mln loss 1.01
EPS loss 15.50 yen loss 23.94 yen loss 40.91 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T